CN100368549C - 一种细菌质粒及其衍生质粒与应用 - Google Patents
一种细菌质粒及其衍生质粒与应用 Download PDFInfo
- Publication number
- CN100368549C CN100368549C CNB2006100662178A CN200610066217A CN100368549C CN 100368549 C CN100368549 C CN 100368549C CN B2006100662178 A CNB2006100662178 A CN B2006100662178A CN 200610066217 A CN200610066217 A CN 200610066217A CN 100368549 C CN100368549 C CN 100368549C
- Authority
- CN
- China
- Prior art keywords
- plasmid
- gene
- sequence
- cgmcc
- microorganism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 145
- 230000001580 bacterial effect Effects 0.000 title claims description 12
- 239000002773 nucleotide Substances 0.000 claims abstract description 14
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 75
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 32
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 claims description 25
- 241000588814 Ochrobactrum anthropi Species 0.000 claims description 24
- 244000005700 microbiome Species 0.000 claims description 22
- 238000011160 research Methods 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 description 32
- 102000004190 Enzymes Human genes 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 20
- 238000000034 method Methods 0.000 description 18
- 230000009182 swimming Effects 0.000 description 18
- 239000000047 product Substances 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000013600 plasmid vector Substances 0.000 description 12
- 230000015556 catabolic process Effects 0.000 description 11
- 238000006731 degradation reaction Methods 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 108091008146 restriction endonucleases Proteins 0.000 description 11
- 230000029087 digestion Effects 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000013599 cloning vector Substances 0.000 description 9
- 101150035026 mobA gene Proteins 0.000 description 9
- 101150086745 pre gene Proteins 0.000 description 9
- 101150061147 preA gene Proteins 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 102100031780 Endonuclease Human genes 0.000 description 8
- 108010042407 Endonucleases Proteins 0.000 description 8
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 8
- 101710150114 Protein rep Proteins 0.000 description 8
- 101710152114 Replication protein Proteins 0.000 description 8
- 230000007613 environmental effect Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 238000010353 genetic engineering Methods 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 6
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000010367 cloning Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 5
- 101150066583 rep gene Proteins 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000002957 persistent organic pollutant Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000010802 sludge Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000588843 Ochrobactrum Species 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 2
- 239000002894 chemical waste Substances 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 238000004939 coking Methods 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- 150000002475 indoles Chemical class 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001394 metastastic effect Effects 0.000 description 2
- 206010061289 metastatic neoplasm Diseases 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229940049547 paraxin Drugs 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 241000590020 Achromobacter Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 101100301559 Bacillus anthracis repS gene Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 101100247969 Clostridium saccharobutylicum regA gene Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101100136641 Escherichia coli (strain K12) pifC gene Proteins 0.000 description 1
- 101100412434 Escherichia coli (strain K12) repB gene Proteins 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 101100184605 Escherichia coli mobA gene Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010060766 Heteroplasia Diseases 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 101100391699 Pseudomonas viridiflava gacA gene Proteins 0.000 description 1
- 241000190932 Rhodopseudomonas Species 0.000 description 1
- 101100301564 Staphylococcus aureus repF gene Proteins 0.000 description 1
- 101100114425 Streptococcus agalactiae copG gene Proteins 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- UCKZMPLVLCKKMO-LHLIQPBNSA-N cephamycin Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](C)[C@]21OC UCKZMPLVLCKKMO-LHLIQPBNSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000005314 correlation function Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000008385 outer phase Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 101150044854 repA gene Proteins 0.000 description 1
- 101150055347 repA2 gene Proteins 0.000 description 1
- 101150107738 repB gene Proteins 0.000 description 1
- 101150043558 repc gene Proteins 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100662178A CN100368549C (zh) | 2006-03-29 | 2006-03-29 | 一种细菌质粒及其衍生质粒与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100662178A CN100368549C (zh) | 2006-03-29 | 2006-03-29 | 一种细菌质粒及其衍生质粒与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1837369A CN1837369A (zh) | 2006-09-27 |
CN100368549C true CN100368549C (zh) | 2008-02-13 |
Family
ID=37014877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100662178A Expired - Fee Related CN100368549C (zh) | 2006-03-29 | 2006-03-29 | 一种细菌质粒及其衍生质粒与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100368549C (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083736A (en) * | 1996-11-22 | 2000-07-04 | Pioneer Hi-Bred International, Inc. | Ochrobactrum anthropi bacteria which degrade moniliformin |
CN1727489A (zh) * | 1997-04-02 | 2006-02-01 | 制药中心有限公司 | 细菌质粒 |
CN1748034A (zh) * | 2003-02-01 | 2006-03-15 | 创新公开有限公司 | 改进的表达元件 |
-
2006
- 2006-03-29 CN CNB2006100662178A patent/CN100368549C/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083736A (en) * | 1996-11-22 | 2000-07-04 | Pioneer Hi-Bred International, Inc. | Ochrobactrum anthropi bacteria which degrade moniliformin |
CN1727489A (zh) * | 1997-04-02 | 2006-02-01 | 制药中心有限公司 | 细菌质粒 |
CN1748034A (zh) * | 2003-02-01 | 2006-03-15 | 创新公开有限公司 | 改进的表达元件 |
Non-Patent Citations (1)
Title |
---|
Molecular characterization of chromosomal class Cβ-lactamase and its regulatory gene in Ochrobactrumanthropi. DAVID NADJAR et al..Antimicrobial Agents and Chemotherapy,Vol.45 No.8. 2001 * |
Also Published As
Publication number | Publication date |
---|---|
CN1837369A (zh) | 2006-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lefèvre et al. | Isolation and characterization of a magnetotactic bacterial culture from the Mediterranean Sea | |
Emtiazia et al. | Production of extra-cellular polymer in Azotobacter and biosorption of metal by exopolymer | |
Lomans et al. | Microbial populations involved in cycling of dimethyl sulfide and methanethiol in freshwater sediments | |
Kragelund et al. | Isolation of lux reporter gene fusions in Pseudomonas fluorescens DF57 inducible by nitrogen or phosphorus starvation | |
JP7473137B2 (ja) | シュードザイマ・アンタクティカの新規菌株 | |
Yanagiya et al. | Novel self-transmissible and broad-host-range plasmids exogenously captured from anaerobic granules or cow manure | |
Sharma et al. | Genome features of Pseudomonas putida LS46, a novel polyhydroxyalkanoate producer and its comparison with other P. putida strains | |
Holloway | Genetics of methylotrophs | |
CN106635904A (zh) | 一种具有降解苯胺能力的鞘氨醇杆菌及其应用 | |
Lemaire et al. | Shewanella decolorationis LDS1 chromate resistance | |
Thornhill et al. | PCR for direct detection of indigenous uncultured magnetic cocci in sediment and phylogenetic analysis of amplified 16S ribosomal DNA | |
CN101935621B (zh) | 一株嗜酸氧化亚铁硫杆菌基因工程菌及其应用 | |
Paget et al. | Development of engineered genomic DNA to monitor the natural transformation of Pseudomonas stutzeri in soil-like microcosms | |
Barton et al. | Environmental microbiology and microbial ecology | |
CN100368549C (zh) | 一种细菌质粒及其衍生质粒与应用 | |
Pratama et al. | Molecular identification of lactic acid bacteria from" budu" of West Sumatera, Indonesia, as a potential probiotic | |
Van Elsas et al. | Plasmid transfer to indigenous bacteria in soil and rhizosphere: problems and perspectives | |
Smalla et al. | Isolation and characterisation of plasmids from bacteria | |
EP1762612A2 (en) | Insertion sequence elements derived from ralstonia solanacearum | |
Vanneste et al. | Copper and streptomycin resistance in Pseudomonas strains isolated from pipfruit and stone fruit orchards in New Zealand | |
JPS59501732A (ja) | 芳香族炭化水素類の微生物学的酸化のための方法および材料 | |
Satvatmanesh et al. | Biosorption of 226 Ra in high level natural radiation areas of Ramsar, Iran | |
Fessler et al. | Conjugative plasmids inhibit extracellular electron transfer in Geobacter sulfurreducens | |
Zhang et al. | The complete sequences and ecological roles of two IncP-1β plasmids, pHB44 and pBS64, isolated from the mycosphere of Laccaria proxima | |
US20060094117A1 (en) | Plasmid-free clone of e. coli strain dsm 6601 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING WEIMING KAITUO CROPS DESIGN CENTER LTD. Free format text: FORMER OWNER: WEIMINGKAITUO AGRO-BIOLOGICAL TECHNOLOGY CO., LTD., BEIJING Effective date: 20071012 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20071012 Address after: 100085 Peking University biological city, No. 39 West Road, Beijing, Haidian District Applicant after: BEIJING WEIMING KAITUO CROP DESIGN CENTER Co.,Ltd. Address before: 100085 Beijing city Haidian District on the West Road No. 39 North biocity cantop company Applicant before: BEIJING WEIMING KAITUO AGRICUL |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WEIMINGKAITUO AGRO-BIOLOGICAL TECHNOLOGY CO., LTD Free format text: FORMER OWNER: BEIJING WEIMING KAITUO CROPS DESIGN CENTER LTD. Effective date: 20081010 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20081010 Address after: Peking University biological city, No. 39 West Road, Beijing, Haidian District Patentee after: BEIJING WEIMING KAITUO AGRICUL Address before: Peking University biological city, No. 39 West Road, Beijing, Haidian District Patentee before: BEIJING WEIMING KAITUO CROP DESIGN CENTER Co.,Ltd. |
|
C56 | Change in the name or address of the patentee |
Owner name: WEIMING BIOLOGICAL AGRICULTURE GROUP CO., LTD. Free format text: FORMER NAME: WEIMINGKAITUO AGRO-BIOLOGICAL TECHNOLOGY CO., LTD., BEIJING |
|
CP01 | Change in the name or title of a patent holder |
Address after: 100085 Haidian District West Road, No. 39, north of the biological city of Beijing Patentee after: SINOBIOWAY BIO-AGRICULTURE GROUP CO.,LTD. Address before: 100085 Haidian District West Road, No. 39, north of the biological city of Beijing Patentee before: BEIJING WEIMING KAITUO AGRICUL |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080213 |